Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium

Clinical Pharmacology and Therapeutics

Volumn 101, Issue 5, 2017, Pages 589-592

  Grossman, R L ^a   Abel, B ^b   Angiuoli, S ^c   Barrett, J C ^d   Bassett, D ^e   Bramlett, K ^f   Blumenthal, G M ^g   Carlsson, A ^h   Cortese, R ⁱ   DiGiovanna, J ⁱ   Davis Dusenbery, B ⁱ   Dittamore, R ^j   Eberhard, D A ^b   Febbo, P ^b   Fitzsimons, M ^a   Flamig, Z ^a   Godsey, J ^f   Goswami, J ^f   Gruen, A ⁱ   Ortuno F ^a   Han, J ^b   Hayes, D ^k   Hicks, J ^h   Holloway, D ⁱ   Hovelson, D ^k   Johnson, J ^d   Juhl, H ^l   Kalamegham, R ^m   Kamal, R ⁿ   Kang, Q ^k   Kelloff, G J ^o   Klozenbuecher, M ⁿ   Kolatkar, A ^h   Kuhn, P ^h   Langone, K ^b   Leary, R ^p   Loverso, P ^c   Manmathan, H ⁱ   Martin, A M ^q   Martini, J ^v   Miller, D ^a   Mitchell, M ^r   Morgan, T ^k   Mulpuri, R ^s   Nguyen, T ^a   Otto, G ^t   Pathak, A ^g   Peters, E ^m   Philip, R ^g   Posadas, E ^u,aa   Reese, D ^s   Reese, M G ⁿ   Robinson, D ^p   Dei Rossi, A ^b   Sakul, H ^v   Schageman, J ^f   Singh, S ^t   Scher, H I ^r   Schmitt, K ^a   Silvestro, A ^p   Simmons, J ^c   Simmons, T ^a   Sislow, J ^a   Talasaz, A ^w   Tang, P ^a   Tewari, M ^k   Tomlins, S ^k   Toukhy, H ^w   Tseng, H R ^u,ab   Tuck, M ^k   Tzou, A ^g   Vinson, J ^r   Wang, Y ^j   Wells, W ^x   Welsh, A ^t   Wilbanks, J ^y   Wolf, J ^s   Young, L ^t   Lee, J S H ^o   Leiman, L C ^z   more..

^a UNIVERSITY OF CHICAGO   (United States)

^b Genomic Health   (United States)

^c Personal Genome Diagnostics   (United States)

^d ASTRAZENECA   (United Kingdom)

^e Immuno Oncology Translational Development   (United States)

^f Thermo Fisher Scientific   (United States)

^g CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Seven Bridges Genomics   (United States)

^j Diagn and Clin Res Pharmingen   (United States)

^k UNIVERSITY OF MICHIGAN   (United States)

^l Indivumed GmbH   (Germany)

^m GENENTECH INC   (United States)

ⁿ Omicia Inc   (United States)

^o NATIONAL CANCER INSTITUTE   (United States)

^p NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^q NOVARTIS PHARMA AG   (Switzerland)

^r MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^s Provista Diagnostics Inc   (United States)

^t FOUNDATION MEDICINE   (United States)

^u CNSI   (United States)

^v PFIZER INC   (United States)

^w Guardant Health   (United States)

^x Open Commons Consortium   (United States)

^y SAGE BIONETWORKS   (United States)

^z BloodPAC   (United States)

^aa CEDARS SINAI MEDICAL CENTER   (United States)

^ab UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; BLOOD ANALYSIS; CLINICAL PROTOCOL; DIAGNOSTIC VALUE; DRUG INDUSTRY; HEALTH CARE NEED; HUMAN; KNOWLEDGE BASE; MALIGNANT NEOPLASM; MEASUREMENT ACCURACY; MEDICAL INFORMATION; NOTE; PRIORITY JOURNAL; REIMBURSEMENT; REPRODUCIBILITY; BLOOD; BOOK; FACTUAL DATABASE; NEOPLASM;

ATLASES AS TOPIC; DATABASES, FACTUAL; HUMANS; NEOPLASMS;

EID: 85017654995     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1002/cpt.666     Document Type: Note

References (7)

1. White House (US). Remarks by the President in State of the Union Address [Internet]. Washington, DC: White House (US); [cited 06 February 2016]. Available from: (2015).
2. cobas EGFR Mutation Test v2, June 2, 2016 [cited 06 February 2016]. Available from: .
3. List of Cleared or Approved Companion Diagnostic Devices (In Vitro and Imaging Tools) [cited 06 February 2016]. Available from: .
4. Parkinson, D.R. et al. Considerations in the development of circulating tumor cell technology for clinical use. J. Transl. Med. 10, 138–157 (2012).
5. Parkinson, D.R. et al. Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancer. Clin. Cancer Res. 20, 1428–1444 (2014).
6. White House (US). Remarks of President Barack Obama — State of the Union Address As Delivered [Internet]. Washington, DC: White House (US); [cited 06 February 2016]. Available from: (2016).
7. Grossman, R.L. et al. Toward a shared vision for cancer genomic data. N. Engl. J. Med. 375, 1109–1112 (2016).